Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganaxolone in PTSD
NCT01339689Phase 2Completed
- Sponsor
- Marinus Pharmaceuticals
- Start
- Apr 2011
- Primary completion
- Jan 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of ganaxolone in post-traumatic stress disorder (PTSD), sponsored by Marinus Pharmaceuticals. Started Apr 2011; status: completed.
02
Drugs
ganaxolone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT01339689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339689.